Contribution of VH replacement products to the generation of anti-HIV antibodies

Clinical Immunology

Volumn 146, Issue 1, 2013, Pages 46-55

  Liao, Hongyan ^a   Guo, Jun tao ^c   Lange, Miles D ^a   Fan, Run ^d   Zemlin, Michael ^e   Su, Kaihong ^a,b   Guan, Yongjun ^f   Zhang, Zhixin ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c University of North Carolina at Charlotte   (United States)

^d University of Alabama at Birmingham   (United States)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Anti HIV antibody; CD4i antibody; Gp120; IgH gene; VH replacement

Indexed keywords

ANTIBODY; ASPARTIC ACID; CD4 ANTIBODY; GLUTAMIC ACID; GLYCOPROTEIN GP 120 ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN; NEUTRALIZING ANTIBODY; PGT ANTIBODY; UNCLASSIFIED DRUG; V3 LOOP ANTIBODY; CD4 ANTIGEN; GLYCOPROTEIN GP 120;

AMINO ACID SEQUENCE; ANTIBODY STRUCTURE; ANTIGEN BINDING; ARTICLE; AUTOIMMUNITY; COMPUTER MODEL; CONTROLLED STUDY; GENE MUTATION; GENE PRODUCT; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOGENETICS; IMMUNOGLOBULIN HEAVY CHAIN GENE; PRIORITY JOURNAL; RECOMBINATION ACTIVATION GENE PRODUCT; VH REPLACEMENT; ANTIBODY SPECIFICITY; CHEMICAL STRUCTURE; CHEMISTRY; COMPLEMENTARITY DETERMINING REGION; GENETICS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; ANTIBODY DIVERSITY; ANTIGENS, CD4; COMPLEMENTARITY DETERMINING REGIONS; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY;

EID: 84874196809     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2012.11.003     Document Type: Article

References (33)

1. Burton D.R., Desrosiers R.C., Doms R.W., Koff W.C., Kwong P.D., Moore J.P., Nabel G.J., Sodroski J., Wilson I.A., Wyatt R.T. HIV vaccine design and the neutralizing antibody problem. Nat. Immunol. 2004, 5:233-236.
2. Burton D.R., Stanfield R.L., Wilson I.A. Antibody vs. HIV in a clash of evolutionary titans. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:14943-14948.
3. Nabel G.J. Immunology. Close to the edge: neutralizing the HIV-1 envelope. Science 2005, 308:1878-1879.
4. Decker J.M., Bibollet-Ruche F., Wei X., Wang S., Levy D.N., Wang W., Delaporte E., Peeters M., Derdeyn C.A., Allen S., Hunter E., Saag M.S., Hoxie J.A., Hahn B.H., Kwong P.D., Robinson J.E., Shaw G.M. Antigenic conservation and immunogenicity of the HIV coreceptor binding site. J. Exp. Med. 2005, 201:1407-1419.
5. Wei X., Decker J.M., Wang S., Hui H., Kappes J.C., Wu X., Salazar-Gonzalez J.F., Salazar M.G., Kilby J.M., Saag M.S., Komarova N.L., Nowak M.A., Hahn B.H., Kwong P.D., Shaw G.M. Antibody neutralization and escape by HIV-1. Nature 2003, 422:307-312.
6. Haynes B.F., Fleming J., St Clair E.W., Katinger H., Stiegler G., Kunert R., Robinson J., Scearce R.M., Plonk K., Staats H.F., Ortel T.L., Liao H.X., Alam S.M. Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 2005, 308:1906-1908.
7. Walker L.M., Huber M., Doores K.J., Falkowska E., Pejchal R., Julien J.P., Wang S.K., Ramos A., Chan-Hui P.Y., Moyle M., Mitcham J.L., Hammond P.W., Olsen O.A., Phung P., Fling S., Wong C.H., Phogat S., Wrin T., Simek M.D., Koff W.C., Wilson I.A., Burton D.R., Poignard P. Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 2011, 477:466-470.
8. Pejchal R., Doores K.J., Walker L.M., Khayat R., Huang P.S., Wang S.K., Stanfield R.L., Julien J.P., Ramos A., Crispin M., Depetris R., Katpally U., Marozsan A., Cupo A., Maloveste S., Liu Y., McBride R., Ito Y., Sanders R.W., Ogohara C., Paulson J.C., Feizi T., Scanlan C.N., Wong C.H., Moore J.P., Olson W.C., Ward A.B., Poignard P., Schief W.R., Burton D.R., Wilson I.A. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science 2011, 334:1097-1103.
9. Huang C.C., Venturi M., Majeed S., Moore M.J., Phogat S., Zhang M.Y., Dimitrov D.S., Hendrickson W.A., Robinson J., Sodroski J., Wyatt R., Choe H., Farzan M., Kwong P.D. Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:2706-2711.
10. Huang C.C., Tang M., Zhang M.Y., Majeed S., Montabana E., Stanfield R.L., Dimitrov D.S., Korber B., Sodroski J., Wilson I.A., Wyatt R., Kwong P.D. Structure of a V3-containing HIV-1 gp120 core. Science 2005, 310:1025-1028.
11. Kwong P.D., Wyatt R., Robinson J., Sweet R.W., Sodroski J., Hendrickson W.A. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998, 393:648-659.
12. Rajewsky K. Clonal selection and learning in the antibody system. Nature 1996, 381:751-758.
13. Bassing C.H., Swat W., Alt F.W. The mechanism and regulation of chromosomal V(D)J recombination. Cell 2002, 109:S45-S55.
14. Schatz D.G., Swanson P.C. V(D)J recombination: mechanisms of initiation. Annu. Rev. Genet. 2011, 45:167-202.
15. Nussenzweig M.C. Immune receptor editing: revise and select. Cell 1998, 95:875-878.
16. Nemazee D., Weigert M. Revising B cell receptors. J. Exp. Med. 2000, 191:1813-1817.
17. H replacement. Immunol. Rev. 2004, 197:231-242.
18. H replacement in mice and humans. Trends Immunol. 2007, 28:132-137.
19. H gene replacement. Ann. N. Y. Acad. Sci. 2003, 987:270-273.
20. H gene replacement to the primary B cell repertoire. Immunity 2003, 19:21-31.
21. Chen C., Nagy Z., Prak E.L., Weigert M. Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing. Immunity 1995, 3:747-755.
22. Chen C., Nagy Z., Radic M.Z., Hardy R.R., Huszar D., Camper S.A., Weigert M. The site and stage of anti-DNA B-cell deletion. Nature 1995, 373:252-255.
23. Chen C., Prak E.L., Weigert M. Editing disease-associated autoantibodies. Immunity 1997, 6:97-105.
24. Cascalho M., Wong J., Wabl M. VH gene replacement in hyperselected B cells of the quasimonoclonal mouse. J. Immunol. 1997, 159:5795-5801.
25. Lopez-Macias C., Kalinke U., Cascalho M., Wabl M., Hengartner H., Zinkernagel R.M., Lamarre A. Secondary rearrangements and hypermutation generate sufficient B cell diversity to mount protective antiviral immunoglobulin responses. J. Exp. Med. 1999, 189:1791-1798.
26. Koralov S.B., Novobrantseva T.I., Konigsmann J., Ehlich A., Rajewsky K. Antibody repertoires generated by VH replacement and direct VH to JH joining. Immunity 2006, 25:43-53.
27. Kirkham P.M., Mortari F., Newton J.A., Schroeder H.W. Immunoglobulin VH clan and family identity predicts variable domain structure and may influence antigen binding. EMBO J. 1992, 11:603-609.
28. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., Bourne P.E. The Protein Data Bank. Nucleic Acids Res. 2000, 28:235-242.
29. Sali A., Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 1993, 234:779-815.
30. Zemlin M., Klinger M., Link J., Zemlin C., Bauer K., Engler J.A., Schroeder H.W., Kirkham P.M. Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures. J. Mol. Biol. 2003, 334:733-749.
31. Kleinfield R., Hardy R.R., Tarlinton D., Dangl J., Herzenberg L.A., Weigert M. Recombination between an expressed immunoglobulin heavy-chain gene and a germline variable gene segment in a Ly 1+ B-cell lymphoma. Nature 1986, 322:843-846.
32. H joining mechanism in heavy-chain-negative (null) pre-B cells results in heavy-chain production. Nature 1986, 322:840-842.
33. Lutz J., Muller W., Jack H.M. VH replacement rescues progenitor B cells with two nonproductive VDJ alleles. J. Immunol. 2006, 177:7007-7014.